Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 9;75(3):4202.
doi: 10.18597/rcog.4202.

Prevalence, characterization, and risk factors of gestational anemia in Quindío, Colombia, 2018-2023

[Article in English, Spanish]
Affiliations

Prevalence, characterization, and risk factors of gestational anemia in Quindío, Colombia, 2018-2023

[Article in English, Spanish]
Franklin José Espitia De La Hoz et al. Rev Colomb Obstet Ginecol. .

Abstract

Objectives: To describe the prevalence and characterize gestational anemia in women attending prenatal care in the department of Quindío, Colombia, and to identify associated risk factors.

Material and methods: An analytical crosssectional study was conducted. Out of 1,003 pregnant women, 307 were selected. The study included pregnant women aged 18 years or older who attended a prenatal care program at three high-complexity private institutions in Armenia (Quindío, Colombia) from 2018 to 2023, providing a five-year observation window. Pregnant women with a diagnosis of fetal malformations and hemolytic disease, those who changed healthcare centers, or moved out of Quindío were excluded.

Results: The mean age of the participants was 28.14 ± 5.27 years. The prevalence of gestational anemia was identified as 26.38 %, with an average hemoglobin level of 9.82 ± 1.74 g/dL. Of these, 12.37 % had hemoglobin levels of 10.1-10.9 g/dL (mild anemia), 8.46 % had levels of 7.1-10.0 g/dL (moderate anemia), and 5.53 % had levels below 7.0 g/dL (severe anemia). In the third trimester, the prevalence of anemia increased to 41.97 % (n = 34/81), with 91.35 % (n = 74/81) of cases being iron-deficiency anemia. A BMI of < 18.5 (OR: 15.46; 95 % CI: 7.13-28.59), multiple pregnancy (OR: 9.73; 95 % CI: 1.49-26.83), and a history of pregestational anemia (OR: 7.43; 95 % CI: 4.52-9.13) were associated with gestational anemia.

Conclusions: The prevalence of gestational anemia is over 25 % and increases in the third trimester. It is important to identify risk factors during preconception evaluation and prenatal care.

Objetivos: describir la prevalencia y caracterizar la anemia gestacional en mujeres que asisten a control prenatal en el departamento del Quindío (Colombia), y describir los factores de riesgo asociados.

Materiales y métodos: estudio analítico de corte transversal. De 1.003 embarazadas se seleccionaron 307 mujeres. Se incluyeron gestantes ≥ 18 años, que asistieron al programa de control prenatal en tres instituciones privadas de alta complejidad, en Armenia (Quindío, Colombia), entre 2018 y 2023, para una ventana de observación de cinco años. Se excluyeron embarazadas con diagnóstico de malformaciones fetales y enfermedad hemolítica, las que se cambiaron de centro de atención o se mudaron del Quindío.

Resultados: la edad media de las participantes fue de 28,14 ± 5,27 años. Se identificó una prevalencia de anemia gestacional del 26,38 %, siendo la hemoglobina promedio de 9,82 ± 1,74 g/dL. El 12,37 % presentó hemoglobina de 10,1-10,9 g/dL (anemia leve), 8,46 % de 7,1-10,0 g/dL (anemia moderada) y 5,53 % inferior a 7,0 g/dL (anemia severa). En el tercer trimestre la prevalencia de anemia aumentó al 41,97 % (n = 34/81), siendo anemia ferropénica en el 91,35 % (n = 74/81). El IMC < 18,5 (OR: 15,46; IC 95 %: 7,13-28,59), embarazo múltiple (OR: 9,73; IC 95 %: 1,49-26,83) y antecedente de anemia pregestacional (OR: 7,43; IC 95 %: 4,52-9,13), se asocian con anemia gestacional.

Conclusiones: la prevalencia de anemia gestacional es mayor del 25 % y aumenta en el tercer trimestre. Es importante identificar los factores de riesgo durante la evaluación preconcepcional y en el control prenatal.

Keywords: Anemia; Iron; Pregnancy; Prevalence; Risk factors.

PubMed Disclaimer

Conflict of interest statement

Conflicto de intereses: Los autores declaran no tener ningún conflicto de intereses.

Similar articles

References

    1. Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci. 2000;(900):125–136. doi: 10.1111/j.1749-6632.2000.tb06223.x. - DOI - PubMed
    1. Rosas M, Ortiz M, Dávila R, González A. Prevalencia y factores predisponentes de anemia en el embarazo en una clínica de primer nivel. Rev Hematol Mex. 2016;17(2):107–113.
    1. Espitia F, Orozco L. Anemia en el embarazo, un problema de salud que puede prevenirse. Rev Méd UIS. 2013;26(3):45–50.
    1. Ajepe A, Okunade K, Sekumade A, Daramola E, Beke M, Ijasan O, et al. Prevalence and foeto-maternal effects of iron deficiency anaemia among pregnant women in Lagos, Nigeria. PLoS One. 2020;15(1):e0227965. doi: 10.1371/journal.pone.0227965. - DOI - PMC - PubMed
    1. Oaks B, Jorgensen J, Baldiviez L, Adu-Afarwuah S, Maleta K, Okronipa H, et al. Prenatal iron deficiency and replete iron status are associated with adverse birth outcomes, but associations differ in Ghana and Malawi. J Nutr. 2019;149(3):513–521. doi: 10.1093/jn/nxy278. - DOI - PMC - PubMed

Publication types